Literature DB >> 18413485

Orthostatic hypercoagulability: a novel physiological mechanism to activate the coagulation system.

Muhannad Masoud1, Galit Sarig, Benjamin Brenner, Giris Jacob.   

Abstract

Orthostatic stress causes significant plasma shift and raises transmural pressure in lower extremities, resulting in an increase in endothelial activation and plasma proteins concentrations, possibly including coagulation factors. This may lead to activation of the coagulation system during standing. To test this hypothesis, we recruited 18 healthy volunteers (9 females and 9 males; mean age: 25+/-1.2 years; body mass index: 21.7+/-0.5 kg/m(2)). Hemodynamics, plasma shift (extrapolated from sequential hematocrit concentration), plasma proteins, and coagulation tests, including procoagulants; fibrinogen, factor V, and factor VIII activity; prothrombin fragments 1 and 2; and endothelial activation-related factors (tissue factor and von Willebrand factor), as well as protein C global pathway, were determined at rest supine and at 15 minutes, 30 minutes, and 60 minutes of still standing. Thirty minutes of standing caused a decrease in plasma volume by 12.0+/-0.5% and an increase in plasma protein by 13.0+/-0.7%. Fibrinogen, factor V, and factor VIII activity rose by 12.0+/-1.2%, 13.0+/-1.0%, and 40.0+/-6.0% (P<0.002 for all), respectively. Prothrombin fragments 1 and 2 were elevated by 150.0+/-30.0%. Tissue factor and von Willebrand factor increased by 30.0+/-9.0% and 17.4+/-51.0% (P<0.02 for both), respectively. However, protein C assay results decreased from 0.95+/-0.20 to 0.83+/-0.16 (P<0.001). We hereby introduce a novel physiological mechanism, "orthostatic procoagulation," that should be considered during coagulation tests. Furthermore, it could be extrapolated to the pathophysiology of stasis and venous thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413485     DOI: 10.1161/HYPERTENSIONAHA.108.112003

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  18 in total

1.  Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults.

Authors:  Celia O'Hare; Rose-Anne Kenny; Howard Aizenstein; Robert Boudreau; Anne Newman; Lenore Launer; Suzanne Satterfield; Kristine Yaffe; Caterina Rosano
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Orthostatic Intolerance and Coagulation Abnormalities: An Update.

Authors:  Wei Quan; Yuchen Wang; Selena Chen; Junbao Du
Journal:  Neurosci Bull       Date:  2018-10-13       Impact factor: 5.203

3.  Hemostatic responses to exercise, dehydration, and simulated bleeding in heat-stressed humans.

Authors:  Matthew A Borgman; Morten Zaar; James K Aden; Zachary J Schlader; Daniel Gagnon; Eric Rivas; Jena Kern; Natalie J Koons; Victor A Convertino; Andrew P Cap; Craig Crandall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-09-19       Impact factor: 3.619

Review 4.  Air travel and the risk of thromboembolism.

Authors:  Israel Gavish; Benjamin Brenner
Journal:  Intern Emerg Med       Date:  2010-11-06       Impact factor: 3.397

5.  Postural changes in blood pressure and incidence of ischemic stroke subtypes: the ARIC study.

Authors:  Hiroshi Yatsuya; Aaron R Folsom; Alvaro Alonso; Rebecca F Gottesman; Kathryn M Rose
Journal:  Hypertension       Date:  2011-01-03       Impact factor: 10.190

Review 6.  Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.

Authors:  Sana Khan; Soumya Pati; Shailja Singh; Mohd Akhtar; Piush Khare; Saba Khan; Sadat Shafi; Abul Kalam Najmi
Journal:  Int J Obes (Lond)       Date:  2021-10-22       Impact factor: 5.095

7.  Early activation of the coagulation system during lower body negative pressure.

Authors:  M Zaar; P I Johansson; L B Nielsen; C G Crandall; M Shibasaki; L Hilsted; N H Secher
Journal:  Clin Physiol Funct Imaging       Date:  2009-07-28       Impact factor: 2.273

Review 8.  Orthostatic hypertension-a new haemodynamic cardiovascular risk factor.

Authors:  Kazuomi Kario
Journal:  Nat Rev Nephrol       Date:  2013-11-05       Impact factor: 28.314

9.  Coagulation changes during presyncope and recovery.

Authors:  Gerhard Cvirn; Axel Schlagenhauf; Bettina Leschnik; Martin Koestenberger; Andreas Roessler; Andreas Jantscher; Karoline Vrecko; Guenther Juergens; Helmut Hinghofer-Szalkay; Nandu Goswami
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

10.  Platelet activation after presyncope by lower body negative pressure in humans.

Authors:  Morten Zaar; Chriselda G Fedyk; Heather F Pidcoke; Michael R Scherer; Kathy L Ryan; Caroline A Rickards; Carmen Hinojosa-Laborde; Victor A Convertino; Andrew P Cap
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.